|
Volumn 35, Issue 1, 2003, Pages 203-206
|
Mega dose unfractionated donor bone marrow-derived cell infusion in thymus and periphery - An integrated clinical approach for tolerance in living related renal allografts
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
IMMUNOSUPPRESSIVE AGENT;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
RAPAMYCIN;
TACROLIMUS;
ADOLESCENT;
ADULT;
BONE MARROW CELL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT;
KIDNEY FAILURE;
LIVING DONOR;
LYMPHOCYTOTOXICITY;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THYMUS;
|
EID: 0037322384
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03901-5 Document Type: Conference Paper |
Times cited : (15)
|
References (11)
|